A significantly lower expression of the 374459 isoform was observed in group IV patients who are characterized by high immunohistochemical Ki-67 staining (>50%) compared to patients with Ki-67 ≤ 50% (Figure 4A), indicating an association between the downregulation of 374459 and tumor proliferation. Here, MKI67 is linked to neoplasm.